Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
- PMID: 15680720
- DOI: 10.1016/j.jacc.2004.11.009
Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
Comment on
-
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).J Am Coll Cardiol. 2005 Feb 1;45(3):400-8. doi: 10.1016/j.jacc.2004.08.068. J Am Coll Cardiol. 2005. PMID: 15680719 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical